Chemokines and chemokine receptors: A new strategy for breast cancer therapy

Cancer Med. 2020 Jun;9(11):3786-3799. doi: 10.1002/cam4.3014. Epub 2020 Apr 6.

Abstract

Chemokines and chemokine receptors not only participate in the development of tissue differentiation, hematopoiesis, inflammation, and immune regulation but also play an important role in the process of tumor development. The role of chemokines and chemokine receptors in tumors has been emphasized in recent years. More and more studies have shown that chemokines and chemokine receptors are closely related to the occurrence, angiogenesis, metastasis, drug resistance, and immunity of breast cancer. Here, we review recent progression on the roles of chemokines and chemokine receptors in breast cancer, and discuss the possible mechanism in breast cancer that might facilitate the development of new therapies by targeting chemokines as well as chemokine receptors. Chemokines and chemokine receptors play an important role in the occurrence and development of breast cancer. In-depth study of chemokines and chemokine receptors can provide intervention targets for breast cancer biotherapy. The regulation of chemokines and chemokine receptors may become a new strategy for breast cancer therapy.

Keywords: breast cancer; chemokine receptors; chemokines; therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Chemokines / metabolism*
  • Female
  • Humans
  • Inflammation / prevention & control*
  • Molecular Targeted Therapy*
  • Neovascularization, Pathologic / prevention & control*
  • Receptors, Chemokine / metabolism*

Substances

  • Antineoplastic Agents
  • Chemokines
  • Receptors, Chemokine